CSBR vs HPE · P/E 16, rev $59.4M vs P/E 20, rev $32.19B
Champions Oncology Inc (CSBR) versus Hewlett Packard Enterprise Co (HPE) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Not investment advice. Open the CSBR and HPE stock pages for the full models.
Not investment advice.